ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis
AI Description
This study will monitor the safety and valve performance of the Edwards CENTERA Transcatheter Heart Valve (THV) System in patients with symptomatic, severe, calcific aortic stenosis who are at intermediate operative risk for surgical aortic valve replacement (SAVR).
- Who can join
- child, adult, older adult
- Participants
- 101
- Expected completion
- 2030-07
- Funded by
- industry
Conditions studied
Aortic Valve Stenosis
What is being tested
- DEVICE: TAVR with CENTERA THV
What it measures
- All-cause Death, Number of participants that died, 1 year
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Allegheny General Hospital
Pittsburgh, PA
Ascension Saint Thomas Hospital
Nashville, TN
Ascension St. Vincent Heart Center
Carmel, IN
Barnes-Jewish Hospital
Saint Louis, MO
Baylor Scott & White Medical Center – Temple
Temple, TX
Baylor Scott & White The Heart Hospital – Dallas
Dallas, TX
Baylor Scott & White The Heart Hospital – Plano
Plano, TX
Brigham and Women's Hospital
Boston, MA
Cedars-Sinai Medical Center
Los Angeles, CA
Emory University Hospital Midtown
Atlanta, GA
Henry Ford Health (Detroit)
Detroit, MI
Hospital of the University of Pennsylvania
Philadelphia, PA
MedStar Washington Hospital Center
Washington, DC
Memorial Hermann-Texas Medical Center
Houston, TX
Morristown Medical Center
Morristown, NJ
OhioHealth Riverside Methodist Hospital
Columbus, OH
Sarasota Memorial Hospital
Sarasota, FL
Stanford Health Care
Stanford, CA
The University of Kansas Health System
Kansas City, KS
UCHealth Medical Center of the Rockies
Loveland, CO
Registry entry updated 2025-11-13
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.